Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Takeda Pharmaceutical Company Limited

TKD
Current price
26.88 EUR -0.05 EUR (-0.19%)
Last closed 13.2 EUR
Company
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Berlin Exchange
Capitalization 41 404 388 473 EUR
Yield for 12 month -5.71 %
1Y
3Y
5Y
10Y
15Y
TKD
21.11.2021 - 28.11.2021

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan. Address: 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18.1 EUR

P/E ratio

44.4828

Dividend Yield

4.19 %

Current Year

+26 006 916 069 EUR

Last Year

+24 565 696 282 EUR

Current Quarter

+7 368 163 265 EUR

Last Quarter

+6 409 800 050 EUR

Current Year

+17 304 860 231 EUR

Last Year

+16 977 450 014 EUR

Current Quarter

+5 007 928 290 EUR

Last Quarter

+4 076 726 252 EUR

Key Figures TKD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 161 706 929 617 EUR
Operating Margin TTM 15.92 %
PE Ratio 44.4828
Return On Assets TTM 2.05 %
PEG Ratio 0.7002
Return On Equity TTM 2.04 %
Wall Street Target Price 18.1 EUR
Revenue TTM 4 365 640 821 891 EUR
Book Value 4 916.56 EUR
Revenue Per Share TTM
Dividend Share 185.98 EUR
Quarterly Revenue Growth YOY 14.1 %
Dividend Yield 4.19 %
Gross Profit TTM 2 415 421 011 879 EUR
Earnings per share 0.29 EUR
Diluted Eps TTM 0.29 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 4.9 %
Profit Margin 3.4 %

Dividend Analytics TKD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

1 %

Dividend History TKD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.54
Ex Dividend Date 27.03.2024
Forward Annual Dividend Yield 4.19 %
Last Split Factor
Payout Ratio 195.55 %
Last Split Date
Dividend Date

Stock Valuation TKD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 44.4828
Forward PE 16.9492
Enterprise Value Revenue 2.6005
Price Sales TTM 0.0095
Enterprise Value EBITDA 12.4376
Price Book MRQ 0.8586

Financials TKD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TKD

For 52 weeks

11.48 EUR 14.5 EUR
50 Day MA 12.05 EUR
Shares Short Prior Month
200 Day MA 12.46 EUR
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

B

BCE-PR

15.94 CAD BCE Inc Pref R +0.25 (+2.18%)
Detailed analytics
B

BYRA

0.28 EUR BANK RAKYAT IND -B- 0 (0%)
Detailed analytics
0

0QFT

30.21 EUR Vonovia SE +0.23 (+0.68%)
Detailed analytics
E

ENGI

15.51 EUR Engie S.A. +0.03 (+0.19%)
Detailed analytics
KHC

KHC

35.91 USD Kraft Heinz Co +0.16 (+0.45%)
Detailed analytics